This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers.
Clinical trial NCT01702376 · COMPLETED
Trial details
- NCT number
- NCT01702376
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-03
- Primary completion
- 2013-01-14
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.